Postprandial Hypertriglyceridemia and Cardiovascular Disease: Current and Future Therapies

Ezetimibe ameliorates intestinal chylomicron overproduction and improves glucose tolerance in a diet-induced hamster model of insulin resistance

(2012) Mark Naples et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Exenatide, a Glucagon-like Peptide-1 Receptor Agonist, Acutely Inhibits Intestinal Lipoprotein Production in Healthy Humans

(2012) Changting Xiao et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Apolipoprotein B Synthesis Inhibition With Mipomersen in Heterozygous Familial Hypercholesterolemia

(2012) Evan A. Stein et al.   CIRCULATION

The Complex Genetic Basis of Plasma Triglycerides

(2012) Christopher T. Johansen et al.   Current Atherosclerosis Reports

Antisense oligonucleotides for the treatment of dyslipidaemia

(2012) Maartje E. Visser et al.   EUROPEAN HEART JOURNAL

The DGAT1 Inhibitor LCQ908 Decreases Triglyceride Levels in Patients with the Familial Chylomicronemia Syndrome

(2012) Charles Meyers et al.   Journal of Clinical Lipidology

Mutations inLPL,APOC2,APOA5,GPIHBP1andLMF1in patients with severe hypertriglyceridaemia

(2012) R. P. Surendran et al.   JOURNAL OF INTERNAL MEDICINE

Antisense inhibition of apoB synthesis with mipomersen reduces plasma apoC-III and apoC-III-containing lipoproteins

(2012) Jeremy D. Furtado et al.   JOURNAL OF LIPID RESEARCH

Effects of Therapeutic Lifestyle Change diets high and low in dietary fish-derived FAs on lipoprotein metabolism in middle-aged and elderly subjects

(2012) Esther M. M. Ooi et al.   JOURNAL OF LIPID RESEARCH

AN ANTISENSE INHIBITOR OF APOLIPOPROTEIN C-III LOWERS FASTING PLASMA APOLIPOPROTEIN C-III AND TRIGLYCERIDE CONCENTRATIONS IN HEALTHY VOLUNTEERS

(2012) Vickie Alexander et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

(2012) Marina Cuchel et al.   LANCET

The chronic effects of fish oil with exercise on postprandial lipaemia and chylomicron homeostasis in insulin resistant viscerally obese men

(2012) Karin M Slivkoff-Clark et al.   Nutrition & Metabolism

Ezetimibe beneficially influences fasting and postprandial triglyceride-rich lipoproteins in type 2 diabetes

(2011) Lutgarda Bozzetto et al.   ATHEROSCLEROSIS

Triglycerides and Cardiovascular Disease

(2011) Michael Miller et al.   CIRCULATION

Incretin-based therapies for treatment of postprandial dyslipidemia in insulin-resistant states

(2011) Sarah Farr et al.   CURRENT OPINION IN LIPIDOLOGY

Clinical Relevance of Non-Fasting and Postprandial Hypertriglyceridemia and Remnant Cholesterol

(2011) Borge G. Nordestgaard et al.   Current Vascular Pharmacology

Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement

(2011) Genovefa D. Kolovou et al.   Current Vascular Pharmacology

Effects of the New Dual PPAR /  Agonist GFT505 on Lipid and Glucose Homeostasis in Abdominally Obese Patients With Combined Dyslipidemia or Impaired Glucose Metabolism

(2011) B. Cariou et al.   DIABETES CARE

Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management

(2011) M. John Chapman et al.   EUROPEAN HEART JOURNAL

Exenatide suppresses postprandial elevations in lipids and lipoproteins in individuals with impaired glucose tolerance and recent onset type 2 diabetes mellitus

(2010) Eric A. Schwartz et al.   ATHEROSCLEROSIS

Effect of Ezetimibe on Hepatic Fat, Inflammatory Markers, and Apolipoprotein B-100 Kinetics in Insulin-Resistant Obese Subjects on a Weight Loss Diet

(2010) D. C. Chan et al.   DIABETES CARE

Genetic determinants of plasma triglycerides

(2010) Christopher T. Johansen et al.   JOURNAL OF LIPID RESEARCH

Efficacy and Safety of Mipomersen, an Antisense Inhibitor of Apolipoprotein B, in Hypercholesterolemic Subjects Receiving Stable Statin Therapy

(2010) Fatima Akdim et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial

(2010) Frederick J Raal et al.   LANCET

Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies

(2010)   LANCET

Hypertriglyceridemia and Its Pharmacologic Treatment Among US Adults

(2009) Earl S. Ford et al.   ARCHIVES OF INTERNAL MEDICINE

Methods to assess impaired post-prandial metabolism and the impact for early detection of cardiovascular disease risk

(2009) J. W. Su et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Ezetimibe improves postprandial hyperlipidaemia in patients with type IIb hyperlipidaemia

(2009) D. Masuda et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

Effects of ezetimibe and simvastatin on apolipoprotein B metabolism in males with mixed hyperlipidemia

(2009) André J Tremblay et al.   JOURNAL OF LIPID RESEARCH

Therapeutic Effects of Fibrates in Postprandial Lipemia

(2008) Genovefa D Kolovou et al.   American Journal of Cardiovascular Drugs

Leukocyte Activation by Triglyceride-Rich Lipoproteins

(2008) Arash Alipour et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Extended-Release Niacin Alters the Metabolism of Plasma Apolipoprotein (Apo) A-I and ApoB-Containing Lipoproteins

(2008) Stefania Lamon-Fava et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Overproduction of Very Low–Density Lipoproteins Is the Hallmark of the Dyslipidemia in the Metabolic Syndrome

(2008) Martin Adiels et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

The effect of statin alone or in combination with ezetimibe on postprandial lipoprotein composition in obese metabolic syndrome patients

(2008) Gideon R. Hajer et al.   ATHEROSCLEROSIS

Effect of weight loss on markers of triglyceride-rich lipoprotein metabolism in the metabolic syndrome

(2008) D. C. Chan et al.   EUROPEAN JOURNAL OF CLINICAL INVESTIGATION

An ABC of apolipoprotein C-III: a clinically useful new cardiovascular risk factor?

(2008) D. C. Chan et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Ezetimibe monotherapy for cholesterol lowering in 2,722 people: systematic review and meta-analysis of randomized controlled trials

(2008) A. Pandor et al.   JOURNAL OF INTERNAL MEDICINE

Influence of apoA-V gene variants on postprandial triglyceride metabolism: impact of gender

(2008) Estibaliz Olano-Martin et al.   JOURNAL OF LIPID RESEARCH

Thematic Review Series: Glycerolipids.DGAT enzymes and triacylglycerol biosynthesis

(2008) Chi-Liang Eric Yen et al.   JOURNAL OF LIPID RESEARCH

Aerobic Exercise and Postprandial Lipemia in Men with the Metabolic Syndrome

(2008) MICHAEL L. MESTEK et al.   MEDICINE AND SCIENCE IN SPORTS AND EXERCISE

Differential effect of fenofibrate and atorvastatin on in vivo kinetics of apolipoproteins B-100 and B-48 in subjects with type 2 diabetes mellitus with marked hypertriglyceridemia

(2008) Jean-Charles Hogue et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

The Role of Incretins in Glucose Homeostasis and Diabetes Treatment

(2008) W. Kim et al.   PHARMACOLOGICAL REVIEWS